Richard Christopher
CIK: 0001271244
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Lexaria Bioscience Corp.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 29, 2025LEXX
Lexaria Bioscience Corp.
Purchase(P)Direct15K shares at avg. $0.91$14K - May 15, 2025LEXX
Lexaria Bioscience Corp.
Award(A)DirectStock Options
150K shares- - Dec 3, 2024LEXX
Lexaria Bioscience Corp.
Purchase(P)Direct27.2K shares at avg. $2.47$67K - Dec 2, 2024LEXX
Lexaria Bioscience Corp.
Purchase(P)Direct22.8K shares at avg. $2.24$51K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 29, 2025 | LEXX Lexaria Bioscience Corp. | Purchase(P) | 15,000 | $0.91 | $13,641 | Direct |
| May 15, 2025 | LEXX Lexaria Bioscience Corp. | Award(A) Stock Options | 150,000 | - | - | Direct |
| Dec 3, 2024 | LEXX Lexaria Bioscience Corp. | Purchase(P) | 27,172 | $2.47 | $67,175 | Direct |
| Dec 2, 2024 | LEXX Lexaria Bioscience Corp. | Purchase(P) | 22,828 | $2.24 | $51,217 | Direct |
1-4 of 4 transactions
About CHRISTOPHER RICHARD
CHRISTOPHER RICHARD (SEC CIK 0001271244) files insider reports with the SEC as Chief Executive Officer of Lexaria Bioscience Corp. (LEXX).
Signal8 holds 4 ownership filings by CHRISTOPHER RICHARD (1 Form 3, 3 Form 4), filed between Sep 5, 2024 and Jul 30, 2025. Those filings report 4 transactions, from Dec 2, 2024 to Jul 29, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on CHRISTOPHER RICHARD's filings is in ROCHESTER, NY.
Recent filings by CHRISTOPHER RICHARD
Other insiders filing for Lexaria Bioscience Corp. (LEXX)
- BUNKA CHRISTOPHER, Director
- DOCHERTY JOHN MARTIN, President
- Carle Vanessa, Secretary
- Shankman Michael Elliot, Chief Financial Officer
- Bhullar Baljinder, Director
- Baxter Nicholas W, Director